Alejandro González Veliz/LinkedIn
Jun 23, 2026, 09:36
Alejandro González Veliz: Key Takeaways from the 2026 ACC/AHA Dyslipidemia Guidelines
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“Dyslipidemia management is entering a new era.
The 2026 ACC/AHA Guideline moves beyond LDL-C alone and embraces a more personalized approach to cardiovascular prevention.
- LDL-C goals are back
- Lp(a) should be measured at least once
- ApoB helps uncover residual risk
- Coronary calcium refines risk assessment
- Earlier intervention may change lifelong outcomes
The message is simple: identify risk earlier, treat smarter, and prevent ASCVD before the first event occurs.
Which update do you think will have the greatest impact on your daily practice?
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 11:05Vicky Williams: The Impact of the Stroke Same Day Emergency Care Model on The Outcomes
-
Jun 23, 2026, 10:54Rucha Patil: Honored to Be Appointed to the State-Level Committee on Haemophilia in Maharashtra
-
Jun 23, 2026, 10:48Shamee Shastry: Lewis Antigen Elution and the Challenge of False-Negative Reactions
-
Jun 23, 2026, 10:38Paul Kariuki: A Multidimensional Approach to Strengthening Kenya’s Blood Donation Ecosystem
-
Jun 23, 2026, 10:23Octavio Marques Pontes-Neto: Deeply Honored to Be in the Board of Directors of the World Stroke Organization
-
Jun 23, 2026, 10:22Nawsherwan Mohammad: Thrombocytopenia in Pregnancy – Not Always Benign
-
Jun 23, 2026, 10:10Ahmed S. Mohamed: Comprehensive Evaluation of the Efficacy and Safety of IgG-Pathway Inhibitors in Adult Patients with ITP
-
Jun 23, 2026, 10:01Lisa Jiang: Is the 0.088″ Aspiration Catheter the Future of Stroke Treatment?
-
Jun 23, 2026, 07:45Cerebral Venous Sinus Thrombosis: New Diagnostic Approaches